I disagree. I can’t believe this is a scam with the folks that are running it. If they were no name people with no history of successful management of biotechs I wouldn’t have the confidence.
Sure, they are awful, I repeat, AWFUL at keeping their shareholders apprised, but I think there may be reason behind it.
I think keeping the pps down and the trials from being released is in part while they set up their locations. If they release positive results and go mainstream with them, and only had 2 offices, the supply would not meet the demand.
I just surpassed the million share mark and will keep adding. At the end of the day this really only can go up from here. Given what they are reporting from a patient perspective you have to already assume Q2>Q1.
Plus given the DD on Said it looks like he likes to party and I appreciate that.
News 
Market Data 
Discover 
